Search Result

Results for "

L-Valine

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Linker (1) Akt (12) Amino Acid Derivatives (13) Aminopeptidase (1) Angiotensin Receptor (1) Arginase (12) ATP Synthase (3) Bacterial (12) Biochemical Assay Reagents (2) Drug Intermediate (3) Endogenous Metabolite (12) Isotope-Labeled Compounds (17) Reference Standards (3) Ser/Thr Protease (1)
By Research Areas:	Cancer (3) Endocrinology (1) Infection (15) Inflammation/Immunology (1) Metabolic Disease (11) Neurological Disease (3)
Oligonucleotides:	Solubilizing Agents (1) Freeze-drying Protective Agents (1)

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Natural
Products

Isotope-Labeled Compounds

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N0717

*L-Valine* 4 Publications Verification (S)-Valine	Bacterial Arginase Akt	Infection
L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717R

L-Valine (Standard) (S)-Valine (Standard)	Reference Standards Arginase Akt Bacterial	Infection
L-Valine (Standard) ((S)-Valine (Standard)) is the analytical standard of L-Valine (HY-N0717). This product is intended for research and analytical applications. L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-I1124

L-Valine-d8 1 Publications Verification L-Valine-2,3,4,4,4,5,5,5-d₈	Isotope-Labeled Compounds	Others
L-Valine-d₈ is a deuterated form of L-Valine. L-Valine-d₈ can be used in the labelled synthesis of L-valineamide-d8 intermediate . L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid .

HY-N0717S

L-Valine-15N (S)-Valine-¹⁵N	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹⁵N ((S)-Valine- ¹⁵N) is the ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S4

L-Valine-1-13C (S)-Valine-1-¹³C	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-1- ¹³C ((S)-Valine-1- ¹³C) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S6

L-Valine-13C5 (S)-Valine-¹³C₅	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹³C₅ ((S)-Valine- ¹³C₅) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-136614

H-Val-βNA L-Valine β-naphthylamide	Aminopeptidase	Others
H-Val-βNA (L-Valine β-naphthylamide) can be used as an aminopeptidase and a Valine arylamidase substrate .

HY-I1124R

L-Valine-d8 (Standard) L-Valine-2,3,4,4,4,5,5,5-d8 (Standard)	Isotope-Labeled Compounds Reference Standards	Others
L-Valine-d8 (Standard) is the analytical standard of L-Valine-d8. This product is intended for research and analytical applications. L-Valine-d8 is a deuterated form of L-Valine. L-Valine-d8 can be used in the labelled synthesis of L-valineamide-d8 intermediate . L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid .

HY-N0717S8

L-Valine-d1 (S)-Valine-d₁	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-d₁ ((S)-Valine-d₁) is the deuterium labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S5

L-Valine-2-13C (S)-Valine-¹³C	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-2- ¹³C ((S)-Valine-2- ¹³C) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S9

L-Valine-15N,d8 (S)-Valine-¹⁵N,d₈	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹⁵N,d₈ ((S)-Valine- ¹⁵N,d₈) is the deuterium and ¹⁵N labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S7

L-Valine-1-13C,15N (S)-Valine-1-¹³C,¹⁵N	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-1- ¹³C, ¹⁵N ((S)-Valine-1- ¹³C, ¹⁵N) is the ¹³C- and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S1

L-Valine-13C5,15N (S)-Valine-¹³C₅,¹⁵N	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹³C₅, ¹⁵N ((S)-Valine- ¹³C₅, ¹⁵) is the ¹³C- and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S2

L-Valine-13C5,15N,d8 (S)-Valine-¹³C₅,¹⁵N,d₈	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹³C₅, ¹⁵N,d₈ ((S)-Valine- ¹³C₅, ¹⁵N,d₈) is the deuterium, ¹³C-, and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S3

L-Valine-13C5,15N,d2 (S)-Valine-¹³C₅,¹⁵N,d₂	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹³C₅, ¹⁵N,d₂ ((S)-Valine- ¹³C₅, ¹⁵N,d₂) is the deuterium, ¹³C-, and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-CE01675

L-Valine-CoA L-Valine-coenzyme A	Biochemical Assay Reagents	Metabolic Disease
L-Valine-CoA (L-Valine-coenzyme A) is a coenzyme A derivative .

HY-W007035

H-Val-Ala-OH 1 Publications Verification Valyl-alanine	Endogenous Metabolite Amino Acid Derivatives	Metabolic Disease
H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

HY-W007035R

H-Val-Ala-OH (Standard)	Endogenous Metabolite Amino Acid Derivatives	Metabolic Disease
H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

HY-113126R

3-Hydroxyisobutyric acid (Standard)	Endogenous Metabolite ATP Synthase	Neurological Disease Metabolic Disease
3-Hydroxyisobutyric acid (Standard) is the analytical standard of 3-Hydroxyisobutyric acid. This product is intended for research and analytical applications. 3-Hydroxyisobutyric acid is an important interorgan metabolite, an intermediate in the pathways of l-valine and thymine and a good gluconeogenic substrate.

HY-W016785

Glycyl-L-valine	Endogenous Metabolite	Others
Glycyl-L-valine is a dipeptide that contains glycine and valine.

HY-W002300

Boc-L-Valine 1 Publications Verification	Amino Acid Derivatives	Others
Boc-L-Valine is a valine derivative .

HY-W016785R

*Glycyl-L-valine* (Standard)**	Endogenous Metabolite	Others
Glycyl-L-valine is a dipeptide that contains glycine and valine.

HY-20561

N-Methyl-L-valine	Amino Acid Derivatives	Others
N-Methyl-L-valine is a valine derivative .

HY-W008733

L-Phenylalanyl-L-valine	Amino Acid Derivatives	Others
L-Phenylalanyl-L-valine is a valine derivative .

HY-113126A

3-Hydroxyisobutyric acid sodium	Endogenous Metabolite ATP Synthase	Neurological Disease Metabolic Disease
3-Hydroxyisobutyric acid sodium is an intermediate in the metabolic pathways of L-valine and thymine, and can be found in urine. 3-Hydroxyisobutyric acid sodium is a secreted mediator of endothelial cell fatty acid transport and insulin resistance. 3-Hydroxyisobutyric acid sodium can also inhibit key enzymes of energy metabolism in the cerebral cortex of young rats. The levels of 3-Hydroxyisobutyric acid sodium are closely related to various diseases such as 3-hydroxyisobutyric aciduria, diabetes, and ketoacidosis .

HY-113126

3-Hydroxyisobutyric acid	Endogenous Metabolite ATP Synthase	Neurological Disease Metabolic Disease
3-Hydroxyisobutyric acid is an intermediate in the metabolic pathways of L-valine and thymine, and can be found in urine. 3-Hydroxyisobutyric acid is a secreted mediator of endothelial cell fatty acid transport and insulin resistance. 3-Hydroxyisobutyric acid can also inhibit key enzymes of energy metabolism in the cerebral cortex of young rats. The levels of 3-Hydroxyisobutyric acid are closely related to various diseases such as 3-hydroxyisobutyric aciduria, diabetes, and ketoacidosis .

HY-N1461R

Dihydrodaidzein (Standard) (±)-Dihydrodaidzein (Standard)	Reference Standards Endogenous Metabolite	Metabolic Disease
L-Valine (Standard) is the analytical standard of L-Valine. This product is intended for research and analytical applications. L-Valine (Valine) is a new nonlinear semiorganic material .

HY-W002300S

*Boc-L-Valine-d8*	Isotope-Labeled Compounds	Others
Boc-L-Valine-d₈ is the deuterium labeled Boc-L-Valine .

HY-W002300S1

*Boc-L-Valine-15N*	Isotope-Labeled Compounds Amino Acid Derivatives	Others
Boc-L-Valine- ¹⁵N is the ¹⁵N-labeled Boc-L-Valine (HY-W002300). Boc-L-Valine is a valine derivative .

HY-78733

*N-Fmoc-L-valine* N-succinimidyl ester**	Amino Acid Derivatives	Others
N-Fmoc-L-valine N-succinimidyl ester is a valine derivative .

HY-129263

L-Isoleucyl-L-valine Ile-Val	Ser/Thr Protease	Cancer
L-Isoleucyl-L-valine (Ile-Val) is a dipeptide that induces the bovine trypsinogen-trypsin transition .

HY-W048828

((Benzyloxy)carbonyl)-L-alanyl-L-valine	Amino Acid Derivatives	Others
((Benzyloxy)carbonyl)-L-alanyl-L-valine is a valine derivative .

HY-W048831

(tert-Butoxycarbonyl)-L-valyl-L-valine	Amino Acid Derivatives	Others
(tert-Butoxycarbonyl)-L-valyl-L-valine is a valine derivative .

HY-N0717AR

*D-Valine* (Standard)** (R)-Valine (Standard)	Endogenous Metabolite	Infection Metabolic Disease
D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-N0717A

D-Valine (R)-Valine	Endogenous Metabolite	Infection Metabolic Disease
D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-W011722

N-((Benzyloxy)carbonyl)-N-methyl-L-valine	Amino Acid Derivatives	Others
N-((Benzyloxy)carbonyl)-N-methyl-L-valine is a valine derivative .

HY-143790S

*N-2-(Hydroxyethyl)-L-valine-d4*	Isotope-Labeled Compounds	Others
N-2-(Hydroxyethyl)-L-valine-d₄ is the deuterium labeled N-2-(Hydroxyethyl)-L-valine .

HY-W142823S

*N-(3-Indolylacetyl)-L-valine-d4*	Isotope-Labeled Compounds	Others
N-(3-Indolylacetyl)-L-valine-d₄ is deuterium labeled N-(3-Indolylacetyl)-L-valine .

HY-W008753

Z-L-Val-OH N-Cbz-L-Valine	Biochemical Assay Reagents Drug Intermediate Amino Acid Derivatives	Infection
Z-L-Val-OH (N-Cbz-L-valine) is an amino acid derivative and key intermediate in organic synthesis. Z-L-Val-OH can be used in the synthesis of anti-cytomegalovirus compounds and peptide inhibitors of human spleen plasminogen activator (SFP) and human leukocyte elastase-like protease (ELP) .

HY-N0717AS

*D-Valine-d8* (R)-Valine-d₈	Isotope-Labeled Compounds Endogenous Metabolite	Metabolic Disease
D-Valine-d₈ is the deuterium labeled D-Valine. D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-W013751

Fmoc-Gly-Val-OH N-Fmoc-glycyl-L-Valine	Drug Intermediate	Others
Fmoc-Gly-Val-OH (N-Fmoc-glycyl-L-valine) is a glycyl valine derivative, can be used for the synthesis of drugs or other compounds .

HY-I1111

Fmoc-L-Val-OH FMOC-L-Valine; Fmoc-Valine	Amino Acid Derivatives	Others
Fmoc-L-Val-OH is a valine derivative .

HY-119414

N,N-Dimethyl-L-valine L-N,N-DimethylValine	Drug Intermediate	Others
N,N-Dimethyl-L-valine (L-N,N-Dimethylvaline) is a synthetic intermediate useful for pharmaceutical synthesis.

HY-P0108

Angiotensin II 5-valine Valine angiotensin II; 5-L-Valine angiotensin II	Angiotensin Receptor	Endocrinology Cancer
Angiotensin II 5-valine is an agonist of angiotensin receptor.

HY-20336

Mc-Val-Cit-PABC-PNP Maximum Cited Publications 6 Publications Verification Maleimidocaproyl-L-Valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate	ADC Linker	Others Inflammation/Immunology Cancer
Mc-Val-Cit-PABC-PNP is a cathepsin cleavable linker for antibody-drug conjugates (ADCs) which couples the antibody element to the effecting compound. Mc-Val-Cit-PABC-PNP can be used in the synthesis of ADCs .

HY-P2768

Leucine dehydrogenase, Microorganism LDH, EC 1.4.1.9	Endogenous Metabolite	Metabolic Disease
Leucine dehydrogenase, Microorganism (EC 1.4.1.9) can be purified from Bacillus spheroides. Leucine dehydrogenase catalyzed the oxidative deamination of L-leucine, L-valine, L-isoleucine, L-norvaline, L-alpha-aminobutyrate, and L-norleucine, and the reductive amination of their keto analogues .

HY-41051

(2S)-2-[[(tert-Butoxy)carbonyl](methyl)amino]-3-methylbutanoic acid N-tert-Butoxycarbonyl-N-methyl-L-Valine; N-tert-Butoxycarbonyl-N-methylValine	Amino Acid Derivatives	Others
(2S)-2-[[(tert-Butoxy)carbonyl](methyl)amino]-3-methylbutanoic acid is a valine derivative .

Cat. No.	Product Name	Type

HY-W008753

Z-L-Val-OH N-Cbz-L-Valine	Biochemical Assay Reagents
Z-L-Val-OH (N-Cbz-L-valine) is an amino acid derivative and key intermediate in organic synthesis. Z-L-Val-OH can be used in the synthesis of anti-cytomegalovirus compounds and peptide inhibitors of human spleen plasminogen activator (SFP) and human leukocyte elastase-like protease (ELP) .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N0717

*L-Valine* 4 Publications Verification (S)-Valine	Structural Classification Classification of Application Fields Source classification Other Diseases Amino acids Endogenous metabolite Disease Research Fields	Bacterial Arginase Akt
L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717R

L-Valine (Standard) (S)-Valine (Standard)	Structural Classification Human Gut Microbiota Metabolites Microorganisms other families Source classification Disease markers Endocrine diseases Amino acids Nervous System Disorder Plants Endogenous metabolite Cancer	Reference Standards Arginase Akt Bacterial
L-Valine (Standard) ((S)-Valine (Standard)) is the analytical standard of L-Valine (HY-N0717). This product is intended for research and analytical applications. L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-W007035

H-Val-Ala-OH 1 Publications Verification Valyl-alanine	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite Amino Acid Derivatives
H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

HY-W016785

Glycyl-L-valine	Classification of Application Fields Ketones, Aldehydes, Acids Source classification Other Diseases Endogenous metabolite Disease Research Fields	Endogenous Metabolite
Glycyl-L-valine is a dipeptide that contains glycine and valine.

HY-113126

3-Hydroxyisobutyric acid	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Other Diseases Endogenous metabolite Disease Research Fields	Endogenous Metabolite ATP Synthase
3-Hydroxyisobutyric acid is an intermediate in the metabolic pathways of L-valine and thymine, and can be found in urine. 3-Hydroxyisobutyric acid is a secreted mediator of endothelial cell fatty acid transport and insulin resistance. 3-Hydroxyisobutyric acid can also inhibit key enzymes of energy metabolism in the cerebral cortex of young rats. The levels of 3-Hydroxyisobutyric acid are closely related to various diseases such as 3-hydroxyisobutyric aciduria, diabetes, and ketoacidosis .

HY-W007035R

H-Val-Ala-OH (Standard)	Structural Classification Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Endogenous Metabolite Amino Acid Derivatives
H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

HY-113126R

3-Hydroxyisobutyric acid (Standard)	Structural Classification Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Endogenous Metabolite ATP Synthase
3-Hydroxyisobutyric acid (Standard) is the analytical standard of 3-Hydroxyisobutyric acid. This product is intended for research and analytical applications. 3-Hydroxyisobutyric acid is an important interorgan metabolite, an intermediate in the pathways of l-valine and thymine and a good gluconeogenic substrate.

HY-W016785R

*Glycyl-L-valine* (Standard)**	Structural Classification Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Endogenous Metabolite
Glycyl-L-valine is a dipeptide that contains glycine and valine.

HY-N1461R

Dihydrodaidzein (Standard) (±)-Dihydrodaidzein (Standard)	Structural Classification Human Gut Microbiota Metabolites Flavonoids Other disease Isoflavanones Source classification Disease markers Phenols Polyphenols Endogenous metabolite	Reference Standards Endogenous Metabolite
L-Valine (Standard) is the analytical standard of L-Valine. This product is intended for research and analytical applications. L-Valine (Valine) is a new nonlinear semiorganic material .

HY-N0717AR

*D-Valine* (Standard)** (R)-Valine (Standard)	Structural Classification Source classification Amino acids Endogenous metabolite	Endogenous Metabolite
D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-N0717A

D-Valine (R)-Valine	Infection Structural Classification Classification of Application Fields Source classification Metabolic Disease Amino acids Endogenous metabolite Disease Research Fields	Endogenous Metabolite
D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

Cat. No.	Product Name	Chemical Structure

HY-I1124

L-Valine-d8 1 Publications Verification
L-Valine-d₈ is a deuterated form of L-Valine. L-Valine-d₈ can be used in the labelled synthesis of L-valineamide-d8 intermediate . L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid .

HY-N0717S

L-Valine-15N

L-Valine- ¹⁵N ((S)-Valine- ¹⁵N) is the ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S4

L-Valine-1-13C

L-Valine-1- ¹³C ((S)-Valine-1- ¹³C) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S6

L-Valine-13C5

L-Valine- ¹³C₅ ((S)-Valine- ¹³C₅) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S1

L-Valine-13C5,15N

L-Valine- ¹³C₅, ¹⁵N ((S)-Valine- ¹³C₅, ¹⁵) is the ¹³C- and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-I1124R

L-Valine-d8 (Standard)
L-Valine-d8 (Standard) is the analytical standard of L-Valine-d8. This product is intended for research and analytical applications. L-Valine-d8 is a deuterated form of L-Valine. L-Valine-d8 can be used in the labelled synthesis of L-valineamide-d8 intermediate . L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid .

HY-N0717S8

L-Valine-d1

L-Valine-d₁ ((S)-Valine-d₁) is the deuterium labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S5

L-Valine-2-13C

L-Valine-2- ¹³C ((S)-Valine-2- ¹³C) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S9

L-Valine-15N,d8

L-Valine- ¹⁵N,d₈ ((S)-Valine- ¹⁵N,d₈) is the deuterium and ¹⁵N labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S7

L-Valine-1-13C,15N

L-Valine-1- ¹³C, ¹⁵N ((S)-Valine-1- ¹³C, ¹⁵N) is the ¹³C- and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S2

L-Valine-13C5,15N,d8

L-Valine- ¹³C₅, ¹⁵N,d₈ ((S)-Valine- ¹³C₅, ¹⁵N,d₈) is the deuterium, ¹³C-, and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S3

L-Valine-13C5,15N,d2

L-Valine- ¹³C₅, ¹⁵N,d₂ ((S)-Valine- ¹³C₅, ¹⁵N,d₂) is the deuterium, ¹³C-, and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-W002300S

*Boc-L-Valine-d8*
Boc-L-Valine-d₈ is the deuterium labeled Boc-L-Valine .

HY-W002300S1

*Boc-L-Valine-15N*
Boc-L-Valine- ¹⁵N is the ¹⁵N-labeled Boc-L-Valine (HY-W002300). Boc-L-Valine is a valine derivative .

HY-143790S

*N-2-(Hydroxyethyl)-L-valine-d4*
N-2-(Hydroxyethyl)-L-valine-d₄ is the deuterium labeled N-2-(Hydroxyethyl)-L-valine .

HY-W142823S

*N-(3-Indolylacetyl)-L-valine-d4*
N-(3-Indolylacetyl)-L-valine-d₄ is deuterium labeled N-(3-Indolylacetyl)-L-valine .

HY-N0717AS

*D-Valine-d8*
D-Valine-d₈ is the deuterium labeled D-Valine. D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

Cat. No.	Product Name		Classification

HY-N0717

*L-Valine* 4 Publications Verification (S)-Valine		Freeze-drying Protective Agents Solubilizing Agents
L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

L-Valine

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

NaturalProducts

Isotope-Labeled Compounds

Oligonucleotides

Natural
Products